KR840004442A - 란카시딘의 개량 제조방법 - Google Patents

란카시딘의 개량 제조방법 Download PDF

Info

Publication number
KR840004442A
KR840004442A KR1019830001508A KR830001508A KR840004442A KR 840004442 A KR840004442 A KR 840004442A KR 1019830001508 A KR1019830001508 A KR 1019830001508A KR 830001508 A KR830001508 A KR 830001508A KR 840004442 A KR840004442 A KR 840004442A
Authority
KR
South Korea
Prior art keywords
microorganism
streptomyces
cyclodextrin
culture medium
lancassidine
Prior art date
Application number
KR1019830001508A
Other languages
English (en)
Other versions
KR920009510B1 (ko
Inventor
다까시 스즈끼 (외 2)
Original Assignee
구라바야시 이꾸시로
다께다 야꾸힝 고오교 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 구라바야시 이꾸시로, 다께다 야꾸힝 고오교 가부시끼 가이샤 filed Critical 구라바야시 이꾸시로
Publication of KR840004442A publication Critical patent/KR840004442A/ko
Application granted granted Critical
Publication of KR920009510B1 publication Critical patent/KR920009510B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/02Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/24Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26Ketones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

내용 없음

Description

란카시딘의 개량 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 시클로덱스트린을 배양 배지에 가하여 란카시딘을 제조할 수 있는 미생물을 배양함을 특징으로 하는 란카시딘 항생물질의 개량 제조방법.
  2. 제1항에 있어서, 상기 시클로덱스트린을 미생물이 배양 배지에 접종 또는 이식되기 전에 배양 배지에 가하며, 배지에서의 시클로덱스트린의 농도가 1~150mM임을 특징으로 하는 방법.
  3. 제1항에 있어서, 상기 미생물이스트렙토미세스 var.볼루비리리스(ATCC-21250),스트렙토미세스 그리세오푸스쿠스(ATCC-23910),스트렙토미세스 비올라세오니거(IFC-14166) 또는스트렙토미세스sp.6642-GC1,(IFC-14172)임을 특징으로 하는 방법.
  4. 시클로덱스트린을 함유한 배양 배지에서 란카시딘을 제조할 수 있는 미생물을 배양하고, 생성된 배양 브로스 또는 그의 여과액에 저급 알킬 카르복실레이트를 가하여 에스테르화 반응을 시킴을 특징으로하는 란카시딘 14-아실 유도체 또는 이를 주성분으로 함유한 혼합물의 제조방법.
  5. 제4항에 있어서, 저급 알킬 카르복실레이트가 에틸 아세레이트이며 란카시딘 14-아실 유도체 또는 이를 주성분으로 함유한 혼합물은 란카시딘 C의 14-아세틸 유도체 또는 이를 주성분으로 함유한 혼합물임을 특징으로 하는 방법.
  6. 제5항에 있어서,스트렙토미세스 var. 볼루빌리스(ATCC-21250)가 배양될 미생물임을 특징으로 하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019830001508A 1982-04-12 1983-04-11 란카시딘의 개량 제조방법 KR920009510B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP61342 1982-04-12
JP61342/82 1982-04-12
JP57061342A JPS58179496A (ja) 1982-04-12 1982-04-12 ランカシジンの改良製造法

Publications (2)

Publication Number Publication Date
KR840004442A true KR840004442A (ko) 1984-10-15
KR920009510B1 KR920009510B1 (ko) 1992-10-17

Family

ID=13168356

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830001508A KR920009510B1 (ko) 1982-04-12 1983-04-11 란카시딘의 개량 제조방법

Country Status (11)

Country Link
US (1) US4480033A (ko)
EP (1) EP0091781B1 (ko)
JP (1) JPS58179496A (ko)
KR (1) KR920009510B1 (ko)
CA (1) CA1190165A (ko)
DE (1) DE3367618D1 (ko)
DK (1) DK160510C (ko)
ES (1) ES521361A0 (ko)
HU (1) HU192960B (ko)
SG (1) SG86088G (ko)
ZA (1) ZA832470B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271986A (ja) * 1985-05-27 1986-12-02 Agency Of Ind Science & Technol リンパ系細胞用培地
US4914206A (en) * 1985-10-06 1990-04-03 Takeda Chemical Industries, Ltd. Lankacidin derivatives and production thereof
ES2058057T3 (es) * 1985-12-05 1994-11-01 Takeda Chemical Industries Ltd Derivados de lancacidina y su produccion.
EP0269453B1 (en) * 1986-11-28 1993-03-17 Takeda Chemical Industries, Ltd. A process for producing carboxylic acid esters
US5436140A (en) * 1988-02-02 1995-07-25 Fujisawa Pharmaceutical Co., Ltd. Process for producing WS-9326A and WS-9326B
US5217952A (en) * 1988-02-02 1993-06-08 Fujisawa Pharmaceutical Co., Ltd. Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
JPWO2005073223A1 (ja) * 2004-01-29 2007-09-13 エーザイ・アール・アンド・ディー・マネジメント株式会社 マクロライド系化合物の安定化方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3188272A (en) * 1954-11-29 1965-06-08 Univ Illinois Antibiotic filipin
DK117626C (da) * 1967-05-18 1970-10-19 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af det antibiotiske stof T-2636 eller dets komponenter.
JPS4810442B1 (ko) * 1968-10-26 1973-04-03

Also Published As

Publication number Publication date
DK158983A (da) 1983-10-13
KR920009510B1 (ko) 1992-10-17
EP0091781A1 (en) 1983-10-19
EP0091781B1 (en) 1986-11-12
ES8502159A1 (es) 1984-12-16
DK158983D0 (da) 1983-04-11
DK160510B (da) 1991-03-18
ZA832470B (en) 1983-12-28
JPS6314950B2 (ko) 1988-04-02
DK160510C (da) 1991-08-26
CA1190165A (en) 1985-07-09
SG86088G (en) 1989-06-16
JPS58179496A (ja) 1983-10-20
DE3367618D1 (en) 1987-01-02
HU192960B (en) 1987-08-28
ES521361A0 (es) 1984-12-16
US4480033A (en) 1984-10-30

Similar Documents

Publication Publication Date Title
KR850007983A (ko) 히알우론산 생산의 발효법
KR840002451A (ko) 3-히드록시-ml-236b 유도체의 제조방법
KR950701976A (ko) F0-1289 물질 및 그의 생산방법
ES8506095A1 (es) Un procedimiento para preparar un complejo de compuestos antibioticos que contienen azufre
KR840004442A (ko) 란카시딘의 개량 제조방법
KR960700346A (ko) 면역억제제의 제조방법 및 이에 사용되는 신규 미생물(a process for producing immunosuppressives and a novel microbial species to be employed therein)
DE3066026D1 (en) A method for the production of antibiotic c-15003 p-3
KR840003696A (ko) 2-케토-l-굴론산의 제조방법
KR840002030A (ko) 보르데텔라 속에 속하는 미생물의 배양 방법 및 배양 배지
KR830007830A (ko) 엔듀라시딘 및 그를 위한 미생물의 제조방법
EP0140714A3 (en) Method for the production of phenylalanine ammonia-lyase by fermentation
KR890008325A (ko) 아미노디옥시 만니톨의 제법
ES463206A1 (es) Un metodo para preparar maytansinol, maytanacina o propiona-to de maytansinol.
KR830006425A (ko) 매크로리드의 제조방법
ES395935A1 (es) Un procedimiento para la produccion del antibiotico de ws- 4.545.
KR890014457A (ko) 신규 아족시 화합물 및 그의 제조방법
KR910700331A (ko) 카보닐 그룹을 미생물학적으로 키랄 환원시키는 방법 및 신규한 미생물
KR920002795A (ko) 항생제 발히마이신, 이의 제조방법 및 약제로서 이의 용도
KR830005357A (ko) 나라신의 제조방법
KR830006432A (ko) 헤테로 폴리싸카라이드 s-119의 제법
ES409978A1 (es) Metodo para la produccion de antibioticos no nitrogenados acidos.
KR850007270A (ko) 항암제 LL-D49194α₁,LL-D49194β1,LL-D49194β2,LL-D49194β3,LL-D49194γ,LL-D49194δ,LL-D49194ε,LL-D49194ζ,LL-D49194n,LL-D49194ω1,LL-D49194ω2 및 LL-D49194ω3의 제조방법
KR830010197A (ko) 나라신의 제조방법
KR880002995A (ko) 푸럭토 올리고(Fructo-oligo)당의 제조방법
JPS5521A (en) Production of coenzyme q10 through fermentation

Legal Events

Date Code Title Description
A201 Request for examination
E601 Decision to refuse application
E902 Notification of reason for refusal
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20021007

Year of fee payment: 11

EXPY Expiration of term